doravirine + dolutegravir + lamivudine

This is a combination of three antiretroviral medications: doravirine (a non-nucleoside reverse transcriptase inhibitor, NNRTI), dolutegravir (an integrase strand transfer inhibitor, INSTI), and lamivudine (a nucleoside reverse transcriptase inhibitor, NRTI). Based on the provided information, this specific three-drug combination does not appear to be available as a single approved fixed-dose combination product, though its individual components and other combinations involving these drugs (like doravirine/lamivudine/tenofovir, dolutegravir/lamivudine, or doravirine/dolutegravir dual therapy) are used for HIV treatment.